Modulight (MODU.HE) Stock Analysis & AI Equity Report
Modulight (MODU.HE) overview
Modulight (MODU.HE) stock analysis and AI equity research. For the latest completed financial year, 2024, Modulight reported revenue of EUR 4.1m and operating profit of EUR -8.3m; the year-end share price was 0.96 EUR and market capitalisation was EUR 40.8m. Modulight is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Modulight's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-23. Data will be refreshed during report generation.
About Modulight
Modulight Oyj designs and manufactures medical laser devices and related optics for oncology and ophthalmology, with products also used in genetics, diagnostics, and other life science applications. It offers customized laser solutions, cloud-connected systems, and lifecycle support, and serves pharmaceutical companies, hospitals, cancer centers, and research customers.
Generate the Modulight report
Modulight is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Modulight and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.